We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Global Laboratory Informatics Market to Reach USD 3.16 Billion by 2022

By LabMedica International staff writers
Posted on 20 Sep 2017
Print article
The global laboratory informatics market is projected to grow at a CAGR of 6.4% from USD 2.32 billion in 2017 to USD 3.16 billion by 2022, driven by the increasing need for lab automation, development of integrated lab informatics solutions, regulatory requirements, growing demand in biobanks/biorepositories, academic research institutes, and CROs, and rising awareness.

These are the latest findings of Research and Markets (Dublin, Ireland), a global market research company.

In 2017, the LIMS segment is expected to account for the largest share of the global laboratory informatics market, based on the type of solutions offered, and is also projected to record the highest CAGR during the forecast period, due to the wide range of benefits associated with the use of these systems, including increased workflow efficiencies, easy integration with other lab systems, reduced transcription errors, and better regulatory compliance.

In 2017, the services segment is expected to account for the largest share of the global laboratory informatics market, by component, and record a high growth during the forecast period, driven by technological advancements in solution offerings by various vendors, increasing adoption of cloud-based solutions, growing need for consulting services, and the recurring nature of services.

The on-premise segment is expected to hold the largest share of the global laboratory informatics market, by deployment model, while the cloud-based segment is expected to record the highest CAGR during the forecast period, due to advantages such as on-demand self-serving analytics, absence of upfront capital investment for hardware, extreme capacity flexibility, and a pay-as-you-go pricing model.

In 2017, the life sciences segment is expected to hold the largest share of the global laboratory informatics market, by industry, led by the growing applications of molecular diagnostics, rising outsourcing by pharmaceutical industries, rising need for integrated systems, stringent regulatory guidelines to be followed by pharmaceutical laboratories, increasing number of biobanks/biorepositories due to the growing number of biobanking applications, increasing need to integrate laboratory systems, and growing awareness and availability of technologically-advanced laboratory informatics solutions.

Biobanks/biorepositories are expected to witness the highest growth in the global laboratory informatics market, by type, during the forecast period, due to the demand for high-quality specimens driving the need for automated storage, preparation, and information management to obtain accurate, reliable, and standardized data, government funding for scientific research activities, and growing collaboration between market players to offer laboratory informatics solutions to biobanks.

Related Links:
Research and Markets

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more